These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 7113326)
1. [Heart rate reduction in atrial fibrillation with a rapid ventricular response by Gallopamil, a Ca-antagonist (author's transl)]. Neuss H; Horn HG; Mitrović V; Buss J; Schlepper M Z Kardiol; 1982 May; 71(5):334-9. PubMed ID: 7113326 [TBL] [Abstract][Full Text] [Related]
2. [Regularization of ventricular intervals in atrial fibrillation--electrophysiologic findings on the underlying mechanism]. Neuss H; Golling FR; Schlepper M; Thormann J; Weissmüller P; Kindler M Z Kardiol; 1984 Feb; 73(2):106-12. PubMed ID: 6719983 [TBL] [Abstract][Full Text] [Related]
3. [The new calcium antagonist Ro 11-1781 in the treatment of ventricular tachycardia due to atrial fibrillation]. Brisse B; Bender F; Gülker H; Niehues H Z Kardiol; 1978 Sep; 67(9):609-11. PubMed ID: 716535 [TBL] [Abstract][Full Text] [Related]
4. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?]. Blagova OV; Nedostup AV Ter Arkh; 2006; 78(8):30-8. PubMed ID: 17078214 [TBL] [Abstract][Full Text] [Related]
5. Atrioventricular nodal modification and atrioventricular junctional ablation for control of ventricular rate in atrial fibrillation. Narasimhan C; Blanck Z; Akhtar M J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S146-50. PubMed ID: 9727690 [TBL] [Abstract][Full Text] [Related]
6. Modulation of ventricular rate in permanent atrial fibrillation: randomized, crossover study of the effects of slow-release formulations of gallopamil, diltiazem, or verapamil. Botto GL; Bonini W; Broffoni T Clin Cardiol; 1998 Nov; 21(11):837-40. PubMed ID: 9825197 [TBL] [Abstract][Full Text] [Related]
7. Clinical assessment of clonidine in the treatment of new-onset rapid atrial fibrillation: a prospective, randomized clinical trial. Simpson CS; Ghali WA; Sanfilippo AJ; Moritz S; Abdollah H Am Heart J; 2001 Aug; 142(2):E3. PubMed ID: 11479482 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of heart arrhythmias with calcium antagonists]. Bender F Z Kardiol; 1984; 73 Suppl 2():101-5. PubMed ID: 6084911 [TBL] [Abstract][Full Text] [Related]
9. Verapamil-induced ventricular regularity in atrial fibrillation. Effects of exercise, isoproterenol, atropine and conversion to sinus rhythm. Khalsa A; Olsson SB Acta Med Scand; 1979; 205(6):509-15. PubMed ID: 452946 [TBL] [Abstract][Full Text] [Related]
10. Effects of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate. Hofmann R; Steinwender C; Kammler J; Kypta A; Leisch F Int J Cardiol; 2006 Jun; 110(1):27-32. PubMed ID: 16046015 [TBL] [Abstract][Full Text] [Related]
11. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter. Phillips BG; Gandhi AJ; Sanoski CA; Just VL; Bauman JL Pharmacotherapy; 1997; 17(6):1238-45. PubMed ID: 9399606 [TBL] [Abstract][Full Text] [Related]
12. [Gallopamil infusion for treatment of Prinzmetal angina]. Carlon R; Cappelletti F; Ometto R; Maiolino P; Vincenzi M Cardiologia; 1990 May; 35(5):407-14. PubMed ID: 2125241 [TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of magnesium sulfate, in addition to usual care, for rate control in atrial fibrillation. Davey MJ; Teubner D Ann Emerg Med; 2005 Apr; 45(4):347-53. PubMed ID: 15795711 [TBL] [Abstract][Full Text] [Related]
14. [Hemodynamic and electrophysiologic effects of the new calcium antagonist Ro 11-1781 (author's transl)]. Bödeker K; Bischoff KO; Menken U; Hager W Z Kardiol; 1980 Nov; 69(11):790-6. PubMed ID: 7467662 [TBL] [Abstract][Full Text] [Related]
15. Acute ventricular rate control in atrial fibrillation and atrial flutter. Khan IA; Nair CK; Singh N; Gowda RM; Nair RC Int J Cardiol; 2004 Oct; 97(1):7-13. PubMed ID: 15336799 [TBL] [Abstract][Full Text] [Related]
16. [Retardation of the excitation conduction by propaphenone. Duration and dosage effect relation after oral administration (author's transl)]. Beck OA; Abdulla S; Hochrein H MMW Munch Med Wochenschr; 1975 Aug; 117(35):1369-72. PubMed ID: 809677 [TBL] [Abstract][Full Text] [Related]
17. Focal pharmacological modulation of atrioventricular nodal conduction via implantable catheter: a novel therapy for atrial fibrillation? Sigg DC; Hiniduma-Lokuge P; Coles JA; Falkner P; Rose R; Urban JF; Ujhelyi MR Circulation; 2006 May; 113(20):2383-90. PubMed ID: 16702470 [TBL] [Abstract][Full Text] [Related]
18. [Control of ventricular response in patients with atrial fibrillation]. Touboul P Arch Mal Coeur Vaiss; 1994 Sep; 87 Spec No 3():35-9. PubMed ID: 7786122 [TBL] [Abstract][Full Text] [Related]
19. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study. Davy JM; Herold M; Hoglund C; Timmermans A; Alings A; Radzik D; Van Kempen L; Am Heart J; 2008 Sep; 156(3):527.e1-9. PubMed ID: 18760136 [TBL] [Abstract][Full Text] [Related]
20. Heart rate variability in patients suffering from structural heart disease and decreased AV-nodal conduction capacity. Insights into the formation of heart rate variability. Schwab JO; Eichner G; Schmitt H; Schrickel J; Yang A; Balta O; Lüderitz B; Lewalter T Z Kardiol; 2004 Mar; 93(3):229-33. PubMed ID: 15024591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]